Entering text into the input field will update the search result below

Ironwood Pharma Q4 revenues up 8%; updates guidance

  • Ironwood Pharmaceuticals (NASDAQ:IRWD) Q4 results: Revenues: $94.2M (+7.7%); Operating Income: $22.8M; Net Income: $12.1M; EPS: $0.08; Non-GAAP Loss Per Share: ($0.14) (-16.7%); Quick Assets: $221.4M (-27.5%).
  • 2018 Guidance: R&D Expenses: $160M - 180M; SG&A Expenses: $230M - 250M; Net interest expense: less than $40M.

Recommended For You

More Trending News

About IRWD Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
IRWD--
Ironwood Pharmaceuticals, Inc.